Fusion Pharmaceuticals Inc Investor Relations Material
Latest events
Study Update
Fusion Pharmaceuticals Inc
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Fusion Pharmaceuticals Inc
Access all reports
Fusion Pharmaceuticals Inc. is a clinical-stage oncology company headquartered in Hamilton, Canada, focusing on the development of radiopharmaceuticals as precision medicines. The company's primary efforts are directed towards developing treatments that utilize alpha particle emitting isotopes to selectively target and destroy tumor cells. Fusion Pharmaceuticals leverages its Targeted Alpha Therapies (TAT) platform, which facilitates the connection of these isotopes to various targeting molecules, aiming to deliver alpha particle payloads directly to tumors. This approach underpins its research and insights into the chemistry and biology of alpha-emitting radiopharmaceuticals, alongside its capabilities in target identification, candidate generation, manufacturing, and supply chain. Its shares are listed on the Nasdaq.
Key slides for Fusion Pharmaceuticals Inc
Study Update
Fusion Pharmaceuticals Inc
Study Update
Fusion Pharmaceuticals Inc
Latest articles
Sergey Brin's Role in Shaping the Tech World
Explore Sergei Brin's journey from a Moscow immigrant to co-founding Google, detailing key developments and Alphabet's creation.
29 Apr 2024
Four Decades of IPOs: An Overview
An overview of the stock and IPO market from the 80's until today, highlighting important events and trends.
24 Apr 2024
Larry Page: The Mastermind Behind Google
Explore the journey of Larry Page from a tech-savvy youth to co-founding Google and leading Alphabet.
24 Apr 2024
Ticker symbol
Country
🇨🇦 Canada